Peptídeos

A synthetic peptide for use as a blocking control in assays to test for specificity of ELMO1 antibody, catalog no. 70R-9836

A synthetic peptide for use as a blocking control in assays to test for specificity of HMBS antibody, catalog no. 70R-3343

A synthetic peptide for use as a blocking control in assays to test for specificity of RMI1 antibody, catalog no. 70R-5555

A synthetic peptide for use as a blocking control in assays to test for specificity of VISA antibody, catalog no. 70R-6463

Catalogue peptide; min. 95% purity

ω-Conotoxin CVIA, a 27-amino acid neuropeptide, functions as a blocker of voltage-sensitive calcium channels (VSCCs) [1].

Peptide H-IQVYSR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-IQVYSR-OH include the following: Quantification of Neonatal Fc Receptor and Beta-2 Microglobulin in Human Liver Tissues by Ultraperformance Liquid Chromatography-Multiple Reaction Monitoring X Qiu , MZ Wang - Drug Metabolism and Disposition, 2020 - ASPEThttps://dmd.aspetjournals.org/content/48/10/925.abstract Subcellular fractionation methods for the quantification of endogenous protein in human liver using targeted proteomics X Qiu - 2020 - search.proquest.comhttps://search.proquest.com/openview/1e3c74062db95d405831e29462366272/1?pq-origsite=gscholar&cbl=18750&diss=y Oxidant-mediated modification and cross-linking of beta-2-microglobulin S Jiang , E Fuentes-Lemus , MJ Davies - Free Radical Biology and Medicine, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0891584922001964

Glycyl-L-phenylalanine (Gly-L-Phe) is a dipeptide peptide transport in tracheal epithelial cells degraded in mucosal fluids skin aging and moisturizing.

Recombinant human interferon-β (IFNB) is a therapeutic for specific stages of multiple sclerosis (MS). However, a significant portion of patients develop neutralising antibodies within two years which prevent the clinical efficacy of the treatment- this was correlated to a specific rise in IgG. Sequencing of IFNB1 revealed CD4+ T cell epitope residues (118-132) that contain critical T cell activation residues. Identifying these sequences allows them to be manipulated to provide new interferon treatments that reduce the capacity to induce neutralising antibodies in MS patients. In addition, the critical residue isoleucine has been mutated to valine and shown to reduce the immunological response to this epitope. This IFNB1 (118-132) epitope can be used for immunological investigations as a deimmunised version of the epitope. In addition, it can be used as a control for T cell activation and antibody recognition via immunoassays and immunohistochemistry. This may provide further insights into specific haplotypes correlating to IFNB responses in MS treatment.

Peptide H-KTCPVQLWV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KTCPVQLWV-OH include the following: Tumor protein 53 mutations mapping to its tertiary structure with in-silico prediction of neoepitopic vaccine candidates in bone tumors HN Tipu, AR Arshad - Journal of Experimental Therapeutics and ..., 2015 - researchgate.nethttps://www.researchgate.net/profile/Hamid-Tipu/publication/285322461_Tumor_protein_53_mutation_mapping_to_its_tertiary_structure_with_in-silico_prediction_of_neoepitopic_vaccine_candidates/links/565d66c008aefe619b259bc9/Tumor-protein-53-mutation-mapping-to-its-tertiary-structure-with-in-silico-prediction-of-neoepitopic-vaccine-candidates.pdf

Peptide H-GLDNHTILL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GLDNHTILL-OH include the following: Innate and adaptive immunity toward influenza B viruses L Hensen, K Kedzierska , M Koutsakos - Future Microbiology, 2020 - Future Medicinehttps://www.futuremedicine.com/doi/abs/10.2217/fmb-2019-0340

Peptide H-GNPTVEVDLFTSK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GNPTVEVDLFTSK^-OH include the following: Multiple reaction monitoring of multiple low-abundance transcription factors in whole lung cancer cell lysates JS Kim , Y Lee, MY Lee , J Shin, JM Han - Journal of proteome , 2013 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr3011414 Novel autoantigens in autoimmune hypophysitis I Lupi, KW Broman , SC Tzou , A Gutenberg - Clinical , 2008 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2265.2008.03180.x

A synthetic peptide for use as a blocking control in assays to test for specificity of EPHX1 antibody, catalog no. 70R-5354

A synthetic peptide for use as a blocking control in assays to test for specificity of C9orf127 antibody, catalog no. 70R-7095

A synthetic peptide for use as a blocking control in assays to test for specificity of C6orf182 antibody, catalog no. 70R-3111

Peptide H-IILEGTER-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-IILEGTER-OH include the following: Arthur Viode1, Clemence Fournier2, 3, Agnacašs Camuzat2, 4, Franaca§ois Fenaille1, NeuroCEB Brain Bank, Morwena Latouche2, 4, Fanny Elahi5, Isabelle Le Ber2, 3, 6 LP Sugrue - Genetics of Neurodegenerative Diseases, 2021 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=O8JSEAAAQBAJ&oi=fnd&pg=PA75&dq=(%22H-IILEGTER-OH%22+OR+%22IILEGTER%5E%22+OR+%22H-IILEGTER%5E-OH%22+OR+%22IILEGTER%22)+AND+peptide&ots=ZjyONTXHv9&sig=vPwILNc_t9O7_LaQZpQkkyVULWo New antibody-free mass spectrometry-based quantification reveals that C9ORF72 long protein isoform is reduced in the frontal cortex of hexanucleotide-repeat A Viode, C Fournier, A Camuzat, F Fenaille - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fnins.2018.00589/full

Blocks HIF-1α/β dimerization, not HIF-2α; suppresses VEGF, CAIX in cancer cells; antiangiogenic in HUVECs (IC50 = 1.3 μM).

A synthetic peptide for use as a blocking control in assays to test for specificity of PTPRA antibody, catalog no. 70R-7310

A synthetic peptide for use as a blocking control in assays to test for specificity of IFIH1 antibody, catalog no. 70R-4787

Peptide H-LVVVGAVGVGK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LVVVGAVGVGK^-OH include the following: Optimization of differential ion mobility and segmented ion fractionation to improve proteome coverage Z Wu - 2022 - papyrus.bib.umontreal.cahttps://papyrus.bib.umontreal.ca/xmlui/handle/1866/27427 Mutant proteins as cancer-specific biomarkers Q Wang , R Chaerkady , J Wu - Proceedings of the , 2011 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1019203108 THE CLINICAL PROTEOMICS OF CANCER Q Wang - 2014 - jscholarship.library.jhu.eduhttps://jscholarship.library.jhu.edu/bitstream/1774.2/59387/1/WANG-DISSERTATION-2015.pdf H-Ras and K-Ras oncoproteins induce different tumor spectra when driven by the same regulatory sequences M Drosten , L Simon-Carrasco , I Hernandez-Porras - Cancer research, 2017 - AACRhttps://aacrjournals.org/cancerres/article-abstract/77/3/707/623189 Comparative microsomal proteomics of a model lung cancer cell line NCI-H23 reveals distinct differences between molecular profiles of 3D and 2D cultured JA Kaczmarczyk , RR Roberts, BT Luke, KC Chan - Oncotarget, 2021 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487723/ Comparative Microsomal Proteomics of A Model Lung Cancer Cell Line NCI-H23 Reveals Distinct Differences Between Molecular Profiles of 3D and 2D Cultured J Blonder , JA Kaczmarczyk , RR Roberts, BT Luke - 2020 - researchsquare.comhttps://www.researchsquare.com/article/rs-72194/latest Proteogenomics of colorectal cancer liver metastases: complementing precision oncology with phenotypic data B Blank-Landeshammer , VR Richard , G Mitsa - Cancers, 2019 - mdpi.comhttps://www.mdpi.com/2072-6694/11/12/1907